Companies: 10,795·Total market cap: $144.5T
Lantheus Holdings, Inc.

Lantheus Holdings, Inc.

LNTHNASDAQHealthcare● Active
$100.98
$-1.84(-1.79%)
Market Cap$6.6B
P/E Ratio
52W High$104
52W Low$47.25
Overview

Lantheus Holdings, Inc. (LNTH) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LNTH · as of Jun 8, 2026

Key Statistics

EPS (TTM)$4.21lnth eps ttm · lnth earnings per shareEarnings history
PE Ratio (TTM)24.0×lnth pe ratio ttm · lnth price to earningsPE Ratio deep dive
Revenue (TTM)$1.5Blnth revenue ttm · lnth annual revenueFull revenue history
Dividend YieldNo Dividenddoes lnth pay dividends · lnth dividend yieldDividend history
Shares Outstanding67.5Mlnth shares outstanding · lnth floatShares outstanding history
Next EarningsAug 5, 2026Est.lnth earnings date · lnth next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.54B▲ +0.50% YoY
202320242025
lantheus holdings, inc. revenue · lnth revenue 2025
FY 2025Net Income$233.6M▼ 25.25% YoY
202320242025
lantheus holdings, inc. net income · lnth profit 2025
FY 2025EPS$3.46▼ 23.45% YoY
202320242025
lnth eps · lantheus holdings, inc. earnings per share 2025
TTM:Revenue: $1.55BNet Income: $279.0MEPS: $4.21View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy17 analystsis lnth a buy · lnth analyst rating
Strong Buy
0
Buy
13
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$94.00Low
$100.98Current
$108.50Avg Target7.45% upside
$115.00High
lnth price target · lnth 12 month forecast

Total: 17 · Buy rate: 76.5%

The LNTH analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $108.50, representing +7.45% upside from the current price of $100.98.

Stock Performance

Full History
1D-1.79%
1W+4.69%
1M+8.51%
3M+39.17%
YTD+51.74%
1Y+21.34%
5Y+297.56%

About Lantheus Holdings, Inc.

CEOMary Anne Heino
IPO DateJun 25, 2015
Employees808
CountryUS

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldw…

what is lantheus holdings, inc. · lnth stock overview · lantheus holdings, inc. company profile · who is lantheus holdings, inc. ceo · lnth NASDAQ · lantheus holdings, inc. headquarters · lantheus holdings, inc. business segments

About Stock Overview & Key Data

Lantheus Holdings, Inc. (LNTH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jun 25, 2015. As of the latest trading session, LNTH stock price is $100.98, with a market capitalization of $6.6B. The stock has returned +21.34% over the past 12 months and +51.74% year-to-date.

According to 17 Wall Street analysts, the consensus rating for Lantheus Holdings, Inc. stock is Buy, with an average 12-month price target of $108.50. In fiscal year 2025, Lantheus Holdings, Inc. reported revenue of $1.5B and net income of $233.6M. For detailed data — including Lantheus Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lantheus Holdings, Inc. (LNTH) stock price is $100.98. The stock is traded on NASDAQ under the ticker symbol LNTH. The 52-week range is $47.25 – $104.00.

LNTH stock priceLNTH quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice